Healthtech Startups
17,195 companies tagged Healthtech, with their investors and founders.
Biofrontera develops treatments for actinic keratosis and other common skin conditions, aimed at improving outcomes for dermatology patients and providers. The company operates in the pharmaceutical and dermatology space.
0 investors
BioGrip is a Mexico City-based company that develops prosthetic limbs incorporating artificial intelligence. Its bionic devices are intended for people with limb loss or limb difference who need functional replacements for hands and arms.
0 investors
0 investors
0 investors
0 investors
Biome provides analytics tools for healthcare leaders, focused on improving cardiovascular care outcomes and reducing operational inefficiency. It serves hospitals and cardiac care centers, offering data-driven products including the Biome Performance Network for clinical and operational decision-making.
0 investors
0 investors
Biomerica develops diagnostic products for screening and detection of chronic medical conditions and cancers, offered as at-home tests, point-of-care solutions, and laboratory assays for healthcare providers and consumers.
0 investors
0 investors
0 investors
Biophoundry develops phage-based technologies for therapeutics, diagnostics, and bio-molecular engineering, including its Phax platform aimed at making phage therapy faster and more affordable. The company focuses on precision antibiotics to address antimicrobial resistance, combining synthetic biology, robotics, and data science.
0 investors
0 investors
Biophyx Surgical develops surgical retraction technologies, working with surgeons and stakeholders to create medical devices aimed at improving surgical outcomes. The company operates in the surgical medical device sector, drawing on experience in device R&D, regulatory, and intellectual property.
0 investors
BioQ Pharma is a pharmaceutical company with expertise in biotech development and healthcare technology. The company appears to be focused on pharmaceutical innovation with a board of directors drawn from senior executives with extensive experience in biotech, medical devices, and pharma commercialization.
0 investors
BioRegenx develops hardware and software for microscopy imaging of the endothelial glycocalyx, along with microvascular regenerative products, serving doctors, research scientists, and wellness consumers. The company combines diagnostic imaging technology with regenerative therapeutics in the medical device and wellness sector.
0 investors
BioScape Digital provides interactive patient-facing tools combining audio, text and visual media for healthcare settings, including educational content, provider tools, real-time patient satisfaction feedback, and games to occupy patients during wait times. The product is aimed at healthcare providers to support patient care and engagement.
0 investors
0 investors
0 investors
0 investors
BioStem Technologies develops human amniotic membrane allograft products for advanced surgical care and wound care, used as adjunct treatments for chronic and acute wounds. Its offerings use cryopreserved, hydrated, and dehydrated membrane technologies for clinical and veteran patient populations.
0 investors
Biostream Technologies develops interactive, evidence-based adjunctive therapies for children with autism, designed to improve eye contact, visual behavior, attention, and emotion recognition. The company serves therapists and special education professionals treating autistic children.
0 investors
0 investors
Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
0 investors
BioTuring is a bioinformatics company that builds algorithms and software for analyzing biological data, including single-cell and genomic data. It serves the global scientific research community working to understand biology and improve human health.
0 investors